Researcher.Life Logo

Molecular Therapy - Nucleic Acids : Impact Factor & More

eISSN: 2162-2531pISSN: 2162-2531
JournalOpen Access

Key Metrics

CiteScore
12.9
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
SJR
Q1Drug Discovery
SNIP
1.42
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Molecular Therapy - Nucleic Acids

Molecular Therapy - Nucleic Acids Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher CELL PRESS
Language English
Frequency Quarterly
Article Processing ChargesUSD 3900
Publication Time20
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorAmerican Society of Gene & Cell Therapy
FrequencyQuarterly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
Publication Time 20
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Molecular Therapy - Nucleic Acids ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Molecular Therapy - Nucleic Acids

Dual inhibition of intercellular adhesion molecule-1 and nucleolin reduces RSV infection efficiency in human respiratory organoids.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
LINE-1 retrotransposons: Multifaceted functions and regulatory mechanisms in health and disease.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
Erratum: N1MΨU-modified mRNA vaccines break the mold in fish by enhancing innate immune activation.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
Retraction Notice to: PIWIL1/piRNA-DQ593109 Regulates the Permeability of the Blood-Tumor Barrier via the MEG3/miR-330-5p/RUNX3 Axis.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
Directed evolution of novel AAV capsids for enhanced delivery to mouse and human Schwann cells.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
Dual inhibition of intercellular adhesion molecule-1 and nucleolin reduces RSV infection efficiency in human respiratory organoids.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
LINE-1 retrotransposons: Multifaceted functions and regulatory mechanisms in health and disease.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
Erratum: N1MΨU-modified mRNA vaccines break the mold in fish by enhancing innate immune activation.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
Retraction Notice to: PIWIL1/piRNA-DQ593109 Regulates the Permeability of the Blood-Tumor Barrier via the MEG3/miR-330-5p/RUNX3 Axis.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids
Directed evolution of novel AAV capsids for enhanced delivery to mouse and human Schwann cells.
  • 16 Jun 2026
  • Molecular therapy. Nucleic acids

FAQs on Molecular Therapy - Nucleic Acids